Top

Published in:

01-07-2007 | Case Report

Hodgkin’s lymphoma in a patient with Jo-1 syndrome

Authors: Alexander C. Adam, Christian Grohé, Sebastian Stier, Stefan Gattenlöhner, Zeynep Balta, Reinhard Büttner, Ines Gütgemann

Published in: Virchows Archiv | Issue 1/2007

Abstract

Jo-1 syndrome is an autoimmune disease with autoantibodies against the histidyl tRNA synthetase. Characteristic clinical findings include inflammatory myopathy and interstitial lung disease. We present the first case of a patient with Jo-1 syndrome (positive Jo-1 autoantibodies, myositis, interstitial alveolitis) who developed Hodgkin’s lymphoma of nodular-sclerosing type. Thus, patients with Jo-1 syndrome and immunosuppressive therapy similar to other patients with autoimmune disease are at risk to develop lymphomas and should therefore be monitored carefully.

Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487–1498PubMedCrossRef

Gandhi MK, Tellam JT, Khanna R (2004) Epstein–Barr virus-associated Hodgkin’s lymphoma. Br J Haematol 125:267–281PubMedCrossRef

Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein–Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef

Iwasaki Y, Mohri T, Muraki M, Yasukawa A, Fujimoto T, Takagi O, Tsuya Y, Nakajima S (1992) [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma]. Nihon Kyobu Shikkan Gakkai Zasshi 30:1858–1863PubMed

Lorenzen J, Jux G, Zhao-Hohn M, Klockner A, Fischer R, Hansmann ML (1994) Detection of T-cell clonality in paraffin-embedded tissues. Diagn Mol Pathol 3:93–99

Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360–374

Ott G, Kalla J, Ott MM, Muller-Hermelink HK (1997) The Epstein–Barr virus in malignant non-Hodgkin’s lymphoma of the upper aerodigestive tract. Diagn Mol Pathol 6:134–139PubMedCrossRef

Plotz PH, Rider LG, Targoff IN, Raben N, O’Hanlon TP, Miller FW (1995) NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122:715–724PubMed

Stein H, Delsol G, Pileri S, Said J, Mann R, Poppema S, Jaffe ES, Swerdlow SH (2001) Classical Hodgkin lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, p 245

10.

Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HL (2004) Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatology (Oxford) 43:389–390CrossRef

11.

Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344PubMedCrossRef

Title: Hodgkin’s lymphoma in a patient with Jo-1 syndrome
Authors: Alexander C. Adam
Christian Grohé
Sebastian Stier
Stefan Gattenlöhner
Zeynep Balta
Reinhard Büttner
Ines Gütgemann
Publication date: 01-07-2007
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 1/2007
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-007-0429-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hodgkin’s lymphoma in a patient with Jo-1 syndrome

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2007

Over-estimation of radiation-induced malignancy after the Chernobyl accident

Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions

Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases

Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma

Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells

Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma